Epidemiological characteristics of carbapenemase-producing Enterobacteriaceae outbreaks in the Republic of Korea between 2017 and 2022
Open Access
- 31 August 2023
- journal article
- research article
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (4) , 312-320
Abstract
Objectives: We aimed to describe the epidemiological characteristics of carbapenemase-producing Enterobacteriaceae (CPE) outbreaks in healthcare settings in the Republic of Korea between 2017 and 2022.Methods: Under the national notifiable disease surveillance system, we obtained annual descriptive statistics regarding the isolated species, carbapenemase genotype, healthcare facility type, outbreak location and duration, and number of patients affected and recommended interventions. We used epidemiological investigation reports on CPE outbreaks reported to Korea Disease Control and Prevention Agency from June 2017 to September 2022.Results: Among the 168 reports analyzed, Klebsiella pneumoniae (85.1%) was the most frequently reported species, while K. pneumoniae carbapenemase (KPC, 82.7%) was the most common carbapenemase genotype. Both categories increased from 2017 to 2022 (p<0.01). General hospitals had the highest proportion (54.8%), while tertiary general hospitals demonstrated a decreasing trend (p<0.01). The largest proportion of outbreaks occurred exclusively in intensive care units (ICUs, 44.0%), and the frequency of concurrent outbreaks in ICUs and general wards increased over time (p<0.01). The median outbreak duration rose from 43.5 days before the coronavirus disease 2019 (COVID-19) pandemic (2017–2019) to 79.5 days during the pandemic (2020–2022) (p=0.01), and the median number of patients associated with each outbreak increased from 5.0 to 6.0 (p=0.03). Frequently recommended interventions included employee education (38.1%), and 3 or more measures were proposed for 45.2% of outbreaks.Conclusion: In the Republic of Korea, CPE outbreaks have been consistently dominated by K. pneumoniae and KPC. The size of these outbreaks increased during the COVID-19 pandemic. Our findings highlight the need for continuing efforts to control CPE outbreaks using a multimodal approach, while considering their epidemiology.Keywords
This publication has 10 references indexed in Scilit:
- Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019Antimicrobial Resistance & Infection Control, 2022
- Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A ReviewInfection and Drug Resistance, 2021
- Risk Factors for Carbapenemase-Producing Enterobacterales Infection or Colonization in a Korean Intensive Care Unit: A Case–Control StudyAntibiotics, 2020
- Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition at a Community-based HospitalKorean Journal of Clinical Pharmacy, 2020
- Nosocomial Outbreak Caused by NDM-5 and OXA-181 Carbapenemase Co-producing Escherichia coliInfection & Chemotherapy, 2019
- Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Control of Carbapenem-resistant Enterobacteriaceae,Acinetobacter baumannii, andPseudomonas aeruginosain Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental StudiesClinical Infectious Diseases, 2018
- A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2018
- Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of IsolationInfection Control & Hospital Epidemiology, 2017
- The global epidemiology of carbapenemase-producing EnterobacteriaceaeVirulence, 2016